The ChondrOx study investigates the biology of chondrosarcoma to develop new therapies for this rare bone tumour.

• Dr Sally Flecture shared: “Replication stress is key to understanding how chondrosarcoma develops and becomes more aggressive.”
• Research goals: To create accurate models of chondrosarcoma to test treatments and develop new therapies for patients.

The Laboratory Research Assistant, Mariella Gonsalves, contributes to advancing osteosarcoma research through her work in the Dubrowsky Laboratory.

• Mariella’s role: From lab maintenance to designing experiments, Mariella is an essential part of the research team.
• Mariella shared: “I am excited to be part of a team making a significant impact in osteosarcoma research.”

Thanks to Mr Dubrowsky’s legacy, Dr Lucas Souza now leads the Dubrowsky Laboratory as its full-time manager, driving the next stage of development.

• Dr Souza’s achievements: From managing the lab’s operations to securing funding for new projects.
• Key research bids: Focusing on innovative therapies, lab infrastructure and rare sarcoma cell lines.

The operational funding from Mr Dubrowsky’s legacy has enhanced the lab’s capabilities and enabled the launch of vital research projects.

• Lab upgrades: New equipment and consumables ensure the lab can continue cutting-edge research.
• Ongoing projects: These include research on bone cancer therapies, spinal conditions and degenerative diseases.